Similar articles

• The study of CTLA-4 and vitamin D receptor polymorphisms in the Romanian type 1 diabetes population.

  Guja C, Marshall S, Welsh K, Merriman M, Smith A, Todd JA, Ionescu-Tîrgoviste C. Guja C, et al. J Cell Mol Med. 2002 Jan-Mar;6(1):75-81. doi: 10.1111/j.1582-4934.2002.tb00312.x. J Cell Mol Med. 2002. PMID: 12003670 Free PMC article.
• Effect of adenovirus-mediated gene transfer with CTLA4-Ig gene in organ transplantation.

  Hayashi S, Namii Y, Guan-Lin M, Dai-Kaku L, Kobayashi T, Nagasaka T, Yokoyama I, Hamada H, Takagi H. Hayashi S, et al. Transplant Proc. 1999 Aug;31(5):1944-5. doi: 10.1016/s0041-1345(99)00220-1. Transplant Proc. 1999. PMID: 10455927 No abstract available.
• CTLA-4 gene polymorphism confers susceptibility to insulin-dependent diabetes mellitus (IDDM) independently from age and from other genetic or immune disease markers. The Belgian Diabetes Registry.

  Van der Auwera BJ, Vandewalle CL, Schuit FC, Winnock F, De Leeuw IH, Van Imschoot S, Lamberigts G, Gorus FK. Van der Auwera BJ, et al. Clin Exp Immunol. 1997 Oct;110(1):98-103. doi: 10.1046/j.1365-2249.1997.5121410.x. Clin Exp Immunol. 1997. PMID: 9353155 Free PMC article.
• CTLA4 gene haplotypes cannot protect from IDDM in the presence of high-risk HLA DQ8 or DQ2 alleles in German families.

  Donner H, Seidl C, Braun J, Siegmund T, Herwig J, Seifried E, Usadel KH, Badenhoop K. Donner H, et al. Diabetes. 1998 Jul;47(7):1158-60. doi: 10.2337/diabetes.47.7.1158. Diabetes. 1998. PMID: 9648843 Review. No abstract available.
• Genetic susceptibility to the development of autoimmune disease.

  Heward J, Gough SC. Heward J, et al. Clin Sci (Lond). 1997 Dec;93(6):479-91. doi: 10.1042/cs0930479. Clin Sci (Lond). 1997. PMID: 9497784 Review.